Article (Scientific journals)
A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes
Gallon, R.; Mühlegger, B.; Wenzel, S.-S. et al.
2019In Human Mutation, 40 (5), p. 649-655
Peer Reviewed verified by ORBi
 

Files


Full Text
humu.23721.pdf
Publisher postprint (552.58 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Constitutional mismatch repair deficiency; Article; DNA barcoding; T cell lymphoma; Alleles; Brain Neoplasms; Colorectal Neoplasms; DNA Mismatch Repair; Genetic Association Studies; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Leukocytes; Microsatellite Instability; Microsatellite Repeats; Neoplastic Syndromes, Hereditary
Abstract :
[en] Constitutional mismatch repair deficiency (CMMRD) is caused by germline pathogenic variants in both alleles of a mismatch repair gene. Patients have an exceptionally high risk of numerous pediatric malignancies and benefit from surveillance and adjusted treatment. The diversity of its manifestation, and ambiguous genotyping results, particularly from PMS2, can complicate diagnosis and preclude timely patient management. Assessment of low-level microsatellite instability in nonneoplastic tissues can detect CMMRD, but current techniques are laborious or of limited sensitivity. Here, we present a simple, scalable CMMRD diagnostic assay. It uses sequencing and molecular barcodes to detect low-frequency microsatellite variants in peripheral blood leukocytes and classifies samples using variant frequencies. We tested 30 samples from 26 genetically-confirmed CMMRD patients, and samples from 94 controls and 40 Lynch syndrome patients. All samples were correctly classified, except one from a CMMRD patient recovering from aplasia. However, additional samples from this same patient tested positive for CMMRD. The assay also confirmed CMMRD in six suspected patients. The assay is suitable for both rapid CMMRD diagnosis within clinical decision windows and scalable screening of at-risk populations. Its deployment will improve patient care, and better define the prevalence and phenotype of this likely underreported cancer syndrome. © 2019 The Authors. Human Mutation Published by Wiley Periodicals, Inc.
Disciplines :
Genetics & genetic processes
Author, co-author :
Gallon, R.;  Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
Mühlegger, B.;  Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria
Wenzel, S.-S.;  Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria
Sheth, H.;  Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
Hayes, C.;  Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
Aretz, S.;  Institute of Human Genetics, Biomedical Centre, University Hospital Bonn, Bonn, Germany
Dahan, K.;  Centre de génétique humaine, Institut de pathologie et génétique (IPG), Gosselies, Belgium
Foulkes, W.;  Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, QC, Canada, Department of Human Genetics, McGill University, Montreal, QC, Canada, Department of Medical Genetics, McGill University Health Centre, Montreal, QC, Canada, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
Kratz, C. P.;  Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
Ripperger, T.;  Department of Human Genetics, Hannover Medical School, Hannover, Germany
Azizi, A. A.;  Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria
Baris Feldman, H.;  The Genetics Institute, Rambam Health Care Campus, and The Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
Chong, A.-L.;  Department of Human Genetics, McGill University, Montreal, QC, Canada, Department of Medical Genetics, McGill University Health Centre, Montreal, QC, Canada, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
Demirsoy, U.;  Department of Pediatric Oncology, Kocaeli University, Kocaeli, Turkey
Florkin, Benoit ;  Université de Liège - ULiège
Imschweiler, T.;  Pediatric Oncology, Helios-Klinikum, Krefeld, Germany
Januszkiewicz-Lewandowska, D.;  Department of Pediatric Oncology, Hematology and Transplantation, Poznań University of Medical Sciences, Poznań, Poland
Lobitz, S.;  Department of Pediatric Oncology/Pediatric Hematology, Kliniken der Stadt Köln gGmbH, Children's Hospital Amsterdamer Strasse, Köln, Germany
Nathrath, M.;  Pediatric Hematology and Oncology, Klinikum Kassel, Kassel, Germany, Department of Pediatrics, Pediatric Oncology Center, Technische Universität München, Munich, Germany
Pander, H.-J.;  Institut für Klinische Genetik, Olgahospital, Stuttgart, Germany
Perez-Alonso, V.;  Pediatrics Department, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain
Perne, C.;  Institute of Human Genetics, Biomedical Centre, University Hospital Bonn, Bonn, Germany
Ragab, I.;  Pediatrics Department, Hematology-Oncology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Rosenbaum, T.;  Department of Pediatrics, Sana Kliniken Duisburg, Duisburg, Germany
Rueda, D.;  Hereditary Cancer Laboratory, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain
Seidel, M. G.;  Research Unit Pediatric Hematology and Immunology, Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, Medical University Graz, Graz, Austria
Suerink, M.;  Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands
Taeubner, J.;  Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children´s Hospital, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany
Zimmermann, S.-Y.;  Department of Pediatric Hematology and Oncology, Children's Hospital, University Hospital, Frankfurt, Germany
Zschocke, J.;  Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria
Borthwick, G. M.;  Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
Burn, J.;  Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
Jackson, M. S.;  Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
Santibanez-Koref, M.;  Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
Wimmer, K.;  Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria
More authors (25 more) Less
Language :
English
Title :
A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes
Publication date :
2019
Journal title :
Human Mutation
ISSN :
1059-7794
eISSN :
1098-1004
Publisher :
John Wiley & Sons, Hoboken, United States - New Jersey
Volume :
40
Issue :
5
Pages :
649-655
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
Bernice Barbour Foundation: 328081Cancer Research UK, CRUK: A15934, C569/A24991KWF Kankerbestrijding, DCS: UL‐ 2012–5515
Available on ORBi :
since 22 June 2021

Statistics


Number of views
51 (1 by ULiège)
Number of downloads
1 (1 by ULiège)

Scopus citations®
 
28
Scopus citations®
without self-citations
10
OpenCitations
 
21

Bibliography


Similar publications



Contact ORBi